(Q41654605)

6 October 2017

Anti-miR-33 therapy does not alter the progression of atherosclerosis in low-density lipoprotein receptor-deficient mice (English)

1 reference

6 October 2017

1 reference

1 reference

3

Aldons J Lusis

1 reference

6 October 2017

Tyler J Marquart

1

1 reference

6 October 2017

Judy Wu

series ordinal

2

1 reference

6 October 2017

Ángel Baldán

series ordinal

4

1 reference

6 October 2017

language of work or name

English

0 references

publication date

3 January 2013

1 reference

Arteriosclerosis, Thrombosis, and Vascular Biology

6 October 2017

1 reference

6 October 2017

33

1 reference

6 October 2017

455-458

1 reference

6 October 2017

3

1 reference

MicroRNA-33 deficiency reduces the progression of atherosclerotic plaque in ApoE-/- mice

6 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3587119

miR-33 controls the expression of biliary transporters, and mediates statin- and diet-induced hepatotoxicity

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3587119

MicroRNAs: emerging roles in lipid and lipoprotein metabolism

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3587119

Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3587119

Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3587119

miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3587119

MicroRNA-33 encoded by an intron of sterol regulatory element-binding protein 2 (Srebp2) regulates HDL in vivo

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3587119

Expression of miR-33 from an SREBP2 intron inhibits cholesterol export and fatty acid oxidation

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3587119

miR-33 links SREBP-2 induction to repression of sterol transporters

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3587119

MiR-33 contributes to the regulation of cholesterol homeostasis.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3587119

MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3587119

ABCA1 overexpression in the liver of LDLr-KO mice leads to accumulation of pro-atherogenic lipoproteins and enhanced atherosclerosis

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3587119

Macrophage ATP-binding cassette transporter A1 overexpression inhibits atherosclerotic lesion progression in low-density lipoprotein receptor knockout mice

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3587119

The not-so-simple HDL story: Is it time to revise the HDL cholesterol hypothesis?

18 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23288159

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1161/ATVBAHA.112.300639

1 reference

6 October 2017

1 reference

6 October 2017

1 reference